✦ LIBER ✦

Phase I Trial of Radiation Dose Escalation in Patients with Locally Advanced Hepatocellular Carcinoma: an Interim Report

✍ Scribed by J. Zhao; Z. Ren; G. Jiang

Book ID: 108148591
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 42 KB
Volume: 72
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2008.06.800

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Three-dimensional conformal radiation th

Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose escalation study

✍ Theodore L. Phillips 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 260 KB

A phase I/II trial of TAC-101, an oral s

A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma

✍ Kimberly B. Higginbotham; Richard Lozano; Thomas Brown; Yehuda Z. Patt; Takashi 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 464 KB

A phase I–II trial of cisplatin, hyperth

A phase I–II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies

✍ Terence S Herman; Maxine S Jochelson; Beverly A Teicher; Pamela J Scott; Jorgen 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 911 KB

Phase 1 dose-escalation trial of tremeli

Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma

✍ Brian I. Rini; Mark Stein; Pat Shannon; Simantini Eddy; Allison Tyler; Joe J. St 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

A phase I/II trial of the oral antiangio

A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma

✍ Fumihiko Kanai; Haruhiko Yoshida; Ryosuke Tateishi; Shinpei Sato; Takao Kawabe; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 408 KB

Phase I trial and pharmacokinetics of es

Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma

✍ Philip C. Amrein; John R. Clark; Jeffrey G. Supko; Richard L. Fabian; Chiu C. Wa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

## Abstract ## BACKGROUND Amifostine was developed to protect normal tissues from radiation exposure. The current study was undertaken to determine whether amifostine would allow the delivery of greater numbers of weekly paclitaxel treatments with concomitant, hyperfractionated radiotherapy in pat